| Clinical data | |
|---|---|
| Drug class | Progestin;Progestogen |
LG-2527 is anonsteroidalprogestin which was under development byLigand Pharmaceuticals andWyeth for the treatment ofmenopausal symptoms andbreast cancer, but was never marketed.[1] It reached thepreclinical stage of development prior to the discontinuation of its development in early 2001.[1]
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |